Elon Musk has approached brain chip implant developer Synchron Inc about a potential investment as his own company Neuralink plays catch-up in the race to connect the human brain directly to machines, ...
Synchron completed a $10 million Series A round, which will bankroll a first-in-human trial of its implantable device designed to interpret signals from the brain so paralyzed patients can control ...
- New feature includes AI-driven emotion and language predictions for users in real-time, hands-free without the need for eye tracker or voice control NEW YORK--(BUSINESS WIRE)--Synchron, the ...
Sorrento Therapeutics Inc. has divulged antibody-drug conjugates comprising antibodies targeting HER2 covalently linked to exatecan through a linker. They are ...
Aug 19 (Reuters) - Elon Musk has approached brain chip implant developer Synchron Inc about a potential investment as his own company Neuralink plays catch-up in the race to connect the human brain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results